Zum Hauptinhalt wechseln


Startet die Suche
About us

www.retina-implant.de > News

04.07.2016 - Retina Implant AG Announces Change in Leadership

Following 12 years of successful development at Retina Implant AG, Dr. Walter-G. Wrobel, CEO of the company, has announced his resignation by mutual consent.
More Information:

29.02.2016 - Retina Implant AG Secures €26 Million Round of Private Funding

Funding will Support Expansion into New Centres and Reimbursement for Retina Implant AG's Implant
More Information:

16.11.2015 - Retina Implant AG's Latest Study Results Presented at the 2015 American Academy of Ophthalmology Annual Meeting

Majority of Blind Patients Gain Some Visual Function with the Alpha IMS Implant
More Information:

11.03.2015 - Retina Implant's Founder Awarded the Saudi Ophthalmological Society Gold Medal Lecture Award

Professor Eberhart Zrenner Honored with the Gold Medal for his Presentation on the Artificial Vision Industry at Saudi Ophthalmology 2015 Conference.
More Information:

22.10.2014 - Retina Implant AG Clinical Investigator Presents Global Trial Results at the 2014 American Academy of Ophthalmology Annual Meeting

Study Finds Visual Function Improves in Majority of Patients Implanted with the CE Marked Alpha IMS Subretinal Microchip
More Information:

15.09.2014 - Retina Implant AG's International Clinical Results Presented for the First Time in Europe

Professor Eberhart Zrenner Leads Discussion of Alpha IMS Patient Results One Year Post Implantation at Europe's Largest Ophthalmology Conference
More Information:

11.08.2014 - German Statutory Health Insurance Grants NUB Innovation Status to Retina Implant's Alpha IMS Microchip

Potentially Life-Changing Subretinal Implant Now Available at Six Leading Eye Clinics Across Germany
More Information:

30.06.2014 - Retina Implant AG's Lead Investigator Presents Patient Results at Retina International's 18th World Annual Congress

Professor Eberhart Zrenner Discusses the Future of Artificial Vision at Premier International Ophthalmology Meeting
More Information:

23.06.2014 - Professor Eberhart Zrenner Delivers Keynote Lecture at the RP Fighting Blindness Annual Conference

Retina Implant AG's Lead Clinical Trial Investigator Presents Patient Experiences with the Alpha IMS Subretinal Implant
More Information:

11.06.2014 - Comment on Pixium Vision’s European Initial Public Offering

As a leader in the ophthalmology community, we wanted to personally reach out to make you aware of additional key information with regards to Pixium.
More Information:

12.05.2014 - Retina Implant AG Clinical Trial Results Presented for the First Time at Leading French Ophthalmology Congress

CEO Walter-G Wrobel Shares Patient Results with Subretinal Implants at the 2014 French Society of Ophthalmology (SFO) Congress
More Information:

07.04.2014 - Retina Implant AG Clinical Trial Results Presented at World Ophthalmology Congress 2014

Leading Ophthalmologists Provide an Update on Breakthroughs in Artificial Vision Research
More Information:

18.11.2013 - Retina Implant AG Clinical Trial Results Presented at the 2013 American Academy of Ophthalmology Annual Meeting

Dr. Katarina Stingl Shares Work on CE Marked Subretinal Implant Technology During the Young Ophthalmologists Session
More Information:

06.11.2013 - Retina Implant AG Celebrates 10 Years of Innovation on Its Quest to Restore Useful Vision to People with Retinitis Pigmentosa

Company's 10 Year Anniversary Coincides with Publication of an Article by Co-founder Eberhart Zrenner, M.D. in Leading Scientific Journal, Science Translational Medicine
More Information:

03.07.2013 - Retina Implant AG's Alpha IMS Wins CE Mark

First Wireless Subretinal Device to Restore Useful Vision in Patients Blinded by Retinitis Pigmentosa
More Information:

13.05.2013 - Retina Implant AG Principal Investigators Meet at ARVO 2013 Annual Meeting

Top Retinal Surgeons Discuss Results and Learnings from Second Human Clinical Trial
More Information:

20.02.2013 - Retina Implant AG Announces the Publication of Study Results on its Alpha IMS Implant in Proceedings of the Royal Society B

First Publication of Retina Implant’s Second Human Trial Examining the Ability of its Wireless Microchip to Restore Functional Vision in Patients with Retinitis Pigmentosa
More Information:

28.09.2012 - Retina Implant AG Presents Clinical Trial Update to Advisory Board

Board Members Encouraged and Impressed with Visual Results Achieved to Date
More Information:

07.09.2012 - Retina Implant AG’s Lead Researcher to Present at Annual EURETINA Congress

Professor Eberhart Zrenner to present results from Retina Implant AG’s second human clinical trial
More Information:

09.08.2012 - Retina Implant Patient nominated for Bravery Award

Chris James, the first clinical trial patient in the UK to receive our subretinal implant, has been nominated for Optometry Today’s Optical Bravery Award 2012.
More Information:

10.07.2012 - Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress

Global Momentum Continues for Retina Implant AG's Second Human Clinical Trial
HAMBURG, Germany, July 10, 2012 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that results from the Company's second human clinical trial will be presented at the Retina International World Congress.
More Information:

28.06.2012 - 17. Retina International World Congress

Retina Implant AG together with Okuvision GmbH at the 17. Retina International World Congress in Hamburg on 07/14/2012.
More Information:

04.05.2012 - First Patient in Asia Regains Useful Sight After Receiving Retina Implant AG's Microchip

First of three patients to be implanted at the University of Hong Kong Eye Institute
REUTLINGEN, Germany & HONG KONG, May 03, 2012 (BUSINESS WIRE) -- Retina Implant AG ("Retina Implant"), a leading developer of subretinal implants for the visually
impaired, today announced that the first patient in China to be implanted with its microchip on February 13, 2012 at the University of Hong Kong Eye Institute has since regained useful sight.
More Information:

01.06.2011 - Retina Implant AG Founder Honoures at Euretina

Retina Implant AG Founder Professor Eberhart Zrenner and Research Team Honoured at EURETINA.
More Information:

17.03.2011 - Retina Implant AG Partners with Wills Eye Institute to Bring Artificial Vision Clinical Trials to the United States

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced that they will partner with the Wills Eye Institute in Philadelphia as the lead U.S. clinical trial investigator site. This partnership marks the first time Retina Implant’s subretinal implant technology will be utilized in studies by patients who suffer from retinitis pigmentosa in North America. 
More Information:

10.11.2010 - Over 350 press articles about our results in the Proceedings of the Royal Society B

Our results in the Proceedings of the Royal Society B brought more than 350 press articles, Movies and Newscasts all over the world.
More Information:

04.11.2010 - Proceedings of the Royal Society publish article about Retina Implant

Studies Published in Proceedings of the Royal Society B Validates Retina Implant AG’s Clinical Trial Results.
More Information:

22.10.2010 - Press release from AMD.org about the AAO

The macula degeneration partnership (AMD.org) wrote about the American Academy of Ophthalmology annual meeting.
More Information:

20.10.2010 - Retina Implant presents clinical trial results

Retina implant presents clinical trial results at the American Academy of Ophthalmology annual meeting
More Information:

12.10.2010 - Retina Implant AG opens a new manufacturing plant preparation in place for expected 2011 launch of subretinal implant technology for the Blind

Retina Implant AG today announced the opening of a new manufacturing plant to meet anticipated demand for their implants.
More Information:

15.06.2010 - Vision Quest: Retinal Implants Deliver the Promise of Sight to Damaged Eyes”

Scientific American online, June 2010
Reporter Larry Greenemeier discusses Retina Implant, AG’s subretinal implant that is currently being evaluated to restore useful vision to the blind. The article highlights the success of Retina Implant's first clinical trial as well as the initiation of its second clinical trial across Europe.
More Information:

06.06.2010 - Healthwise: Innovations in Opthamology

WTVI-TV, Charlotte, N.C., June 2010
Dr. David Greenman provides viewers with an overview of Retina Implant’s technology.
More Information:

17.05.2010 - New Technology To Restore Vision

FOX Headline Health, May 2010
Dr. Zrenner talks about a new retina implant that is restoring vision to blind patients.
More Information:


For Media Inquiries, please contact:
Schwartz MSL
Sherry Feldberg / Kirsten Fallon